The acyl-CoA: cholesterol acyl transferase (ACAT) reaction in macrophages is a critical step in atherosclerotic foam cell formation, but little is known about the reaction's sterol substrate specificity. In this report we examine the macrophage ACAT reactivity of the shellfish sterol, desmosterol, and other sterols found in man because of shellfish ingestion or in association with the foam cell diseases sitosterolemia and cerebrotendinous xanthomatosis (CTYX). We first show that the J774 macrophage, a foam cell model with a hyperactive ACAT pathway, synthesizes desmosterol instead of cholesterol and that both endogenous and exogenous desmosterol are substrates and stimulators of the ACAT reaction in these cells. When exogenous desmosterol was added to human monocytederived macrophages, ACAT was stimulated 29-and 4-fold compared with control and cholesterol-treated cells, respectively. Steryl ester mass accumulation in desmosterol-treated human macrophages was 10-fold greater than in control cells and 3-fold greater than in cholesterol-treated cells. Another shellfish sterol, 24-methylene cholesterol, also stimulated ACAT in human macrophages, but most of the xanthomatosis-related sterols did not stimulate ACAT. These data suggest that: (a) the shellfish sterols desmosterol and 24-methylene cholesterol may be atherogenic; and (b) the excessive foam cell formation seen in sitosterolemia and CrX cannot be explained by ACAT hyperreactivity of their associated sterols.
Introduction
Early atherogenesis is characterized by the appearance in the subendothelium of numerous cholesteryl ester (CE)'-filled macrophages or foam cells (1) (2) (3) . The precise cellular and molecular mechanisms of foam cell formation are not known. LDL stimulates the accumulation of CE in two tissue culture macrophages, the mouse peritoneal macrophage and the human monocyte-derived macrophage, only after the lipoprotein has been modified to a form recognized by the scavenger receptor; this receptor, unlike the LDL receptor, is not downregulated by cholesterol (4) . In mouse peritoneal macrophages native LDL can induce CE accumulation only when the cells are in a protein synthesis-inhibited state (5) . In a third tissue culture macrophage, the J774 murine macrophage cell line, both modified and native LDL induce foam cell formation, even when the cells are not protein synthesis inhibited (5, 6) .
In each of these three foam cell models CE accumulation occurs in parallel with activation of the intracellular cholesterol esterifying enzyme, acyl-CoA:CE transferase (ACAT). ACAT is known to catalyze the esterification of fatty acid with internalized lipoprotein-derived cholesterol (reviewed in reference 7) as well as with endogenous cellular cholesterol (8, 9) . Unfortunately, ACAT has not yet been purified so the properties and regulation of this enzymatic pathway are poorly understood. Nonetheless, there is good evidence to suggest that the ACAT pathway plays an important role in foam cell formation. Not only does ACAT catalyze the formation ofthe CE that accumulates in foam cells (4) , but it can also influence other aspects of intracellular cholesterol metabolism that may be important in foam cell formation. For example, hyperactive ACAT in J774 macrophages leads to diminished downregulation of the LDL receptor; this process allows the internalization of large amounts of LDL, which in turn contributes to LDL-induced foam cell formation in these cells (10) .
We have been interested in investigating factors that may regulate the ACAT pathway. One class of potential stimulatory factors are certain noncholesterol sterols. These compounds are of particular interest for the following reasons: (a) microsomal ACAT2 studies have revealed that certain noncholesterol sterols can be esterified as well as or better than cholesterol (11, 12) ; (b) two human diseases in which there is prominent foam cell formation and premature atherosclerosis, sitosterolemia and cerebrotendinous xanthomatosis (CTX), are characterized by elevated plasma and tissue levels of noncholesterol sterols such as plant sterols (1 3, 14) ; and (c) several noncholesterol sterols, such as desmosterol and 24-methylene cholesterol, are abundant in certain types of shellfish, such as Alaskan king crab (15) and oysters, clams, and scallops (16) and are intestinally absorbed (17) . Furthermore, desmosterol, in particular, has been implicated to be atherogenic in animals (18, 19) .
Herein we explore the effect of desmosterol and other sterols on the ACAT pathway in macrophages. Our investiga-tion was stimulated by the unexpected discovery that J774 macrophages have a complete defect in cholesterol biosynthesis and instead accumulate desmosterol. Our report, therefore, evaluates the role of endogenous desmosterol on the ACAT pathway in J774 macrophages and explores the effect of exogenous desmosterol and other sterols on the ACAT pathway in human monocyte-derived macrophages.
Methods
Materials. DME, RPMI 1640 medium, penicillin (10,000 U/ml) and streptomycin (10,000 Mg/ml) solutions, and glutamine (200 mM) solution were obtained from Gibco Laboratories (Grand Island, NY). Defined fetal bovine serum (lot No. 1111683) and iron-supplemented calf serum were obtained from Hyclone Laboratories (Logan, UT). Human serum (type A, Rh') was obtained from normal human volunteers. The Falcon tissue culture plasticware used in these studies was purchased from Fisher Scientific Co. (Pittsburgh, PA). Desmosterol Sa-sitostanol (5a-cholestan-24#-ethyl-3#-o1), cholestanol (5a-cholestan-3,B-ol), 5a-campestanol (Sa-cholestan-24a-methyl-3f-ol), 24 methylene cholesterol (5,24(28)-cholestadien-24-methylen-3f8-ol), campesterol (5-cholesten-24a-methyl-3,-ol), and f3-sitosterol (5-cholesten-24fl-ethyl-3fl-ol) were purchased from Research Plus, Inc.
(Bayonne, NJ). Lovastatin (mevinolin) was kindly provided by Alfred W. Alberts (Merck Sharp, & Dohme Research Laboratories, Rahway, NJ). Before addition to the tissue culture medium, the compound was converted to the sodium salt as described previously (20) Cells. Monolayer cultures of J774 cells and human foreskin fibroblasts (sixth passage) were grown and maintained in DME containing 10% (vol/vol) fetal bovine serum, penicillin (100 U/ml), streptomycin (100 Mg/ml), and glutamine (292 Mg/ml) as described previously (6 For most experiments cells were incubated for 24 h before the beginning of the experiment with DME/10% lipoprotein-deficient serum (LPDS).
Lipoproteins. LDL (density, 1.020-1.063 g/ml) from fresh human plasma and LPDS (d = 1.215 g/ml) from fetal bovine serum or human serum were isolated by preparative ultracentrifugation.
Preparation ofnonsaponifiable lipidsfrom cells and medium. The cell monolayers were first washed three times with cold PBS. The J774 monolayers were scraped with a rubber policeman and after an aliquot was removed for protein determination (23) the cellular lipids were extracted by the method of Folch et al. (24) . The lipids of human fibroblasts, mouse peritoneal macrophages, and human monocyte-derived macrophages were extracted directly from the monolayers in the culture dishes with hexane/isopropanol (3:2 vol/vol; 25). The remaining nonlipid cellular material was dissolved in 0.1 N NaOH and assayed for protein content (23) . The lipids of the tissue culture media were extracted by the method of Bligh and Dyer (26) . Each of the extraction solvents contained a specified amount of ['4C]cholesterol standard. The lipid residue was recovered after the solvents were removed under nitrogen and 0.2 ml 50%O (wt/volj KOH and 3.0 ml methanol were added to each. After heating for 1 h at 80'C, 3.0 ml H20 and 5.0 ml hexane were added and the nonsaponifiable lipids were recovered in the hexane phase. The solvent was removed under nitrogen and the lipid residue was dissolved in ethanol for HPLC injection.
Reverse-phase HPLC ofnonsaponifiable lipids. The procedure was a modification of that of Trzaskos et al. (27) Sterol mass assay. Cellular lipid extracts and HPLC fractions (see above) were assayed for free and esterified sterol content by gas-liquid chromatography as previously described (6) . A 3-ft glass column (2-1838; Supelco, Inc., Bellefonte, PA) packed with 3% OV-17 was used on a gas chromatograph (model 5890; Hewlett-Packard Co., Palo Alto, CA). The N2 carrier gas flow rate was 40 ml/min, the injector and detector temperatures were 275°C, and the oven temperature was 255°C. f3-Sitosterol was used as an internal standard.
Analytical TLC. Two Catalytic reduction. Sterols were dissolved in a small volume of methanol (1-5 mg in 0.5 ml) and cooled on ice. Platinum (IV) oxide ( 1 mg) was added and hydrogen gas was bubbled through the methanol for 2 min. The catalyst was removed by passing the reaction mixture through a glass wool-plugged pipet and the solvent was removed under a stream ofargon. Reduced sterols were then analyzed by GC or GC-mass spectrometry (GC-MS) as described below.
GC-MS. Sterols dissolved in hexane were analyzed on a HP5987A GC-MS fitted with a 12-mDB-I capillary column. The GC was held at 270°C for 1 (29) . The J774 sterol is indistinguishable from desmosterol by these criteria.
Desmosterol is an ACAT substrate and stimulator in J774 macrophages. The ability of J774 macrophages to accumulate CE is dependent on a very active ACAT pathway in these cells (10) . We therefore sought to determine ifa relationship existed between the cells' active ACAT pathway and their block in cholesterol biosynthesis. We were specifically interested in determining if desmosterol, the sterol that accumulates in J774 macrophages (above), was a substrate and/or a stimulator of ACAT in these cells.
We The extracts were then subjected to alkaline hydrolysis and analyzed by HPLC as described in the legend to Fig. 1 that eluted several minutes earlier than cholesterol; this material was subsequently shown to coelute with authentic desmosterol on HPLC and argentation TLC. There was also a minor peak of radioactivity eluting shortly before the major peak of radioactivity; the identity of the material in this peak has not yet been determined. In control experiments using synthetic [3H]cholesteryl ester the TLC-HPLC method described above produced a single peak of tritium-labeled material on HPLC that coeluted with ['4Cjcholesterol standard.
Thus, J774 cells incubated in LPDS synthesize desmosterol and convert this endogenous sterol to desmosteryl ester.
We next addressed the issue of ACAT stimulation by desmosterol. As shown in Fig. 3 A (CON) , J774 cells that had been both preincubated and incubated in DME/LPDS (to accentuate endogenous desmosterol synthesis) had relatively high ACAT activity despite the absence of any exogenous lipoproteins or sterol. In contrast, when human fibroblasts and mouse peritoneal macrophages were incubated under indentical conditions ACAT activity was 0.33±0.04 and 0.34±0.08 nmol/mg cell protein per h, respectively, fivefold less than J774 ACAT activity. Monolayers of J774 macrophages were first incubated for 10 h with DME/10% LPDS and then for an additional 14 h with DME/10% LPDS alone (A, first bar; B, first bar) or with DME/LPDS containing 10 ,gM lovistatin (A, bars 2, 3, and 4; B, bar 2). The cells were then incubated for 6 h with DME/LPDS alone (A, first bar) or with DME/ LPDS containing 10 ,uM lovistatin (A, second bar), lovistatin plus 10 Ag/ml desmosterol (A, third bar), lovistatin plus 10 ,gg/ml cholesterol To examine the role of endogenous desmosterol on LDLinduced ACAT activity in J774 macrophages, the cells were incubated with LDL in the absence or presence of lovastatin (Fig. 3 B) . Confirming our previous reports (6, 10), J774 ACAT activity was shown to be markedly stimulated by the addition of exogenous native LDL (Fig. 3 B [LDL] ). When LDL was added to lovastatin-treated cells (Fig. 3 B [LOV + LDL]), ACAT activity was only slightly decreased (by 11%).3 In a related experiment we measured CE mass accumulation in control and lovastatin-treated J774 macrophages.
When cells were incubated with 300 Mg/ml LDL for 24 h control cells accumulated 97.5±4.2 ,ug CE/mg cell protein (and 4.6 ,g desmosteryl ester/mg) and lovastatin-treated cells accumulated 87.8±9.8 gg CE/mg (n = 3, not statistically different).
Thus, endogenous desmosterol synthesis is not needed for LDL-induced ACAT stimulation and CE accumulation in J774 macrophages.
Exogenous desmosterol stimulates ACA T and causes steryl ester accumulation in human monocyte-derived macrophages and mouse peritoneal macrophages. Our finding that exogenously added desmosterol stimulated ACAT in lovastatintreated J774 macrophages (Fig. 3 A) and also in human fibroblasts (data not shown) prompted us to investigate the effect of desmosterol on ACAT activity in human monocyte-derived macrophages. In addition, we also tested the effect oftwo other shellfish sterols (24-methylene cholesterol and brassicasterol [16] ) and five xanthomatosis-associated sterols (sitostanol, campesterol, campestanol, and sitosterol, which are elevated in the serum of patients with sitosterolemia [13] , and cholestanol, which is elevated in patients with both sitosterolemia and CTX [13, 14] ). The data in Fig. 4 show that 10 ,ug/ml desmosterol (obtained commercially or from LPDS-incubated J774 cells) stimulated ACAT -29-and 4-fold compared with 3 . Under the conditions of this experiment, both specific and total '25I-LDL degradation were increased 1.4-fold in the lovastatin-treated cells. However, this increase in LDL degradation would not be expected to increase ACAT activity proportionately since ACAT stimulation by LDL is mostly saturated at 100 gg/ml LDL (see Fig. 6 in reference 5). Monolayers of human monocyte-derived macrophages, preincubated for 24 h in DME/LPDS, were incubated for 7 h with DME/LPDS alone (Control) or DME/LPDS containing 10 Ag/ml of the indicated sterols. The sterols were added to the media as described in the legend to Fig. 3 control and cholesterol-treated cells, respectively. The greater potency of desmosterol over cholesterol as an ACAT stimulator in these two cell types could not be fully explained by greater cellular uptake of desmosterol compared with cholesterol; the ratios of cell-associated desmosterol to cholesterol at 2, 4, and 7 h were 1.44±0.03, 1.39±0.03, and 1.26±0.02, respectively. Similar data were obtained with mouse peritoneal macrophages: 10 ,g/ml desmosterol stimulated ACAT -70-fold more than control levels and 5-fold more than the activity in cells treated with 10 gg/ml cholesterol despite similar cellular uptake of desmosterol and cholesterol (data not shown). Furthermore, although none of the other sterols tested in human macrophages were as potent as desmosterol in stimulating ACAT, 24-methylene cholesterol and cholestanol (both > 95% by HPLC) substantially stimulated ACAT above control levels and were approximately as potent as cholesterol as ACAT stimulators. Thus, exogenously added desmosterol markedly stimulated ACAT in human monocyte-derived macrophages, and 24-methylene cholesterol and cholestanol were equipotent with cholesterol as ACAT stimulators in these cells.
We next examined the effect of exogenously added desmosterol on steryl ester mass accumulation in human macrophages (Fig. 5) . Cells incubated for 24 h in DME/LPDS (CON) contained only a small amount of steryl ester. The addition of 10 ,g/ml cholesterol throughout the 24-h incubation increased steryl ester content threefold. In both the control and cholesterol-treated samples the sterol moiety of the steryl esters gave a single peak on GC that had the exact retention time of authentic cholesterol. The addition of 10 gg/ml desmosterol throughout the incubation period increased steryl ester accumulation tenfold over the control cells and threefold over the cholesterol-treated cells. In these desmosterol-treated cells the sterol moieties of the steryl esters were resolved into two GC peaks, equal in area, that had retention times identical to authentic cholesterol and authentic desmosterol, respectively. Thus, exogenously added desmosterol led to substantial steryl ester accumulation in human monocyte-derived macrophages; the steryl esters that accumulated appeared to consist of equal amounts of cholesteryl ester and desmosteryl ester. 4 Steryl esters in macrophages undergo a continual cycle of ACAT-mediated esterification and neutral steryl ester hydrolysis (the so-called CE cycle; 31). Thus, the steryl ester mass measurements described above reflect the net result of these two processes (esterification and hydrolysis). The relatively greater potency of desmosterol vs. cholesterol in stimulating steryl ester accumulation could therefore be due to some combination of: (a) a relatively greater potency of desmosterol (vs. cholesterol) in ACAT stimulation; and (b) a relatively greater resistance of desmosteryl ester (vs. CE) to neutral steryl ester hydrolysis. That the former is clearly important was demonstrated by our data with both human monocyte-derived macrophages and mouse peritoneal macrophages (above) showing that desmosterol was markedly more potent than cholesterol in stimulating ['4C]oleate incorporation into steryl esters in the whole-cell ACAT assay. This assay uses a relatively short ['4C]oleate pulse time (1-2 h vs. a t112 for steryl ester hydrolysis of 10-18 h [reference 31 and below]) and thus primarily measures ACAT activity independently of neutral steryl ester hydrolase activity.
If, in addition to the clear role for ACAT in the desmosterol vs. cholesterol effect on steryl ester mass accumulation, there was also a role for neutral steryl ester hydrolysis, then we should be able to demonstrate that macrophages hydrolyze ACAT-derived desmosteryl ester to a lesser extent (and/or lesser rate) than ACAT-derived CE. To address this issue we used a method described by Brown et al. (31) to compare desmosteryl ester hydrolysis with CE hydrolysis in mouse peritoneal macrophages; these cells are known to have an active CE cycle (31), and, like human macrophages, demonstrate greater sterol esterification with desmosterol than with cholesterol (above). The cells were first induced to accumulate either ACAT-derived desmosteryl ester (by a 24-h incubation with desmosterol) or ACAT-derived CE (by a 24-h incubation with acetyl-LDL to obtain enough cellular CE accumulation for the purpose of the experiment). The loaded cells were then incubated (chased) for an additional 24 h in the absence of sterol but in the presence of the specific ACAT inhibitor, Sandoz compound 58-035, to prevent further esterification and reesterification of sterol (32) . CE and desmosteryl ester contents were measured at the beginning (0 h, control), at 10 h, and at the end (24 h) of the 24-h chase period (Fig. 6) ; any decrease in the steryl ester content during the chase period is due to neutral steryl ester hydrolysis (31). In the case of the acetyl-LDLtreated cells we determined previously that 96% of the cellular CE that accumulates during a 24-h incubation is ACAT derived (Tabas, I., and W. Rosoff, unpublished data). Therefore, any subsequent decrease in cellular CE content is almost entirely due to neutral and not lysosomal CE hydrolysis. The data in Fig. 6 Figure 6 . Hydrolysis of ACAT-derived steryl esters in mouse peritoneal macrophages. Monolayers of mouse peritoneal macrophages were incubated for 24 h with DME/10% LPDS containing either 50 zg cholesterol/ml acetyl-LDL or 25 jig/ml desmosterol. The cells were then washed with PBS and harvested immediately (0 h, control) or incubated for an additional 10 or 24 h with DME/LPDS containing 10 jg/ml 58-035. At the end of the incubation period lipid extracts of the cells were assayed for free and total cholesterol and desmosterol mass by GC. Shown are the values for CE mass in the acetyl-LDL-treated cells (-) 
Discussion
The intracellular sterol esterification pathway (the ACAT pathway) in macrophages is thought to play a key role in atherosclerotic foam cell formation (4) . Stimulation or inhibition of this pathway would be expected to promote or retard, respectively, the development of foam cells (4, 10) . In this paper we have explored the macrophage ACAT reactivity (and thus the potential atherogenicity) of desmosterol and other noncholesterol sterols found in shellfish and associated with the foam cell diseases sitosterolemia and CTX.
Desmosterol represents 31% of the sterol in the sterol-rich shellfish, Alaskan king crab (15). Furthermore, this sterol has been implicated as an atherogenic sterol in several animal studies (18, 19) including one study with gerbils (19) in which elevated plasma desmosterol levels were associated with an increased number of atherosclerotic lesions. In this paper desmosterol was shown to be a potent stimulator of the macrophage ACAT reaction (Fig. 4) . In addition, human macrophages were shown to accumulate substantial amounts of steryl ester when incubated with a rather low concentration (10 itg/ml) of desmosterol (Fig. 5) . Half of the steryl esters formed were desmosteryl ester and half were CE. Whether the CE formed was due to conversion of the internalized desmosterol to cholesterol before esterification or to stimulation of esterification of endogenous cellular cholesterol (see references 8 and 9) by desmosterol has not yet been determined. 5 The steryl esters in atherosclerotic foam cells are generally considered to consist of CE (reviewed in reference 33). However, in one experiment in which rabbits were fed a diet containing a small amount of desmosterol (0.05%) as well as cholesterol, atherosclerotic lesions contained a substantial amount of desmosterol (38% of lesion sterol; 18). Thus, this rabbit study and our findings raise the possibility that other steryl esters (e.g., desmosteryl ester) may accumulate in foam cells under certain conditions (i.e., a diet rich in desmosterol-containing shellfish).
Our data with the other sterols suggest that another shellfish sterol, 24-methylene cholesterol (which represents 26, 20, 5. We have determined that when 10 ,ug/ml [3H]desmosterol was added to human macrophages for 24 h, 24% ofthe label was in cholesterol and 76% was in desmosterol. In 24 h human macrophages incubated with 10 ,ug/ml desmosterol accumulated 38.6 gg/mg total desmosterol; thus we may assume (given the 24% conversion data) that 50.6 jig/mg desmosterol entered the cell, of which 38.6 ,ug/mg (76%) remained desmosterol and 12 Ag/mg (24%) was converted to cholesterol. If all of this desmosterol-derived cholesterol were esterified, the mass ofCE (taking into account the fatty acid moiety) from this source would be 20.4 kg/mg. The cells, in fact, accumulated 27.8 ,g/mg CE (Fig. 5 ). Thus, it is possible that most or all of the cholesterol esterified in desmosterol-treated human macrophages could have been derived from the internalized desmosterol. However, since desmosterol is a potent ACAT stimulator in these cells, and since a major substrate for ACAT is endogenous cellular cholesterol (8, 9), at least some of the cholesterol esterified by the cells was probably derived from endogenous cellular stores. and 20% of the sterols in oysters, clams, and scallops, respectively [16] ), may also be atherogenic. Relevant to this issue is the finding by Conner and Lin (17) that shellfish sterols are intestinally absorbed in man and, unlike sitosterol, do not block the absorption of cholesterol. In contrast to our findings with desmosterol and 24-methylene cholesterol, most of the xanthomatosis-associated sterols did not stimulate human macrophage ACAT. Only cholestanol showed reactivity equipotent with cholesterol, but the plasma level of this sterol in sitosterolemia and CTX is only 2% of that of cholesterol (13, 14) . Thus, the mechanism of excessive foam cell formation in these diseases must involve factors other than ACAT hyperreactivity of their associated sterols.
Our finding that macrophages can esterify desmosterol and that macrophage ACAT can be stimulated by other sterols (24-methylene cholesterol and cholestanol), as well as other studies showing that isolated microsomes from other cell types can catalyze the esterification of noncholesterol sterols (11, 12) , probably suggests that ACAT has a somewhat relaxed sterol specificity. Alternatively, but less likely, it is possible that there is more than one sterol-esterifying enzyme. We have determined that the ACAT inhibitor, compound 58-035, effectively inhibits (by 83%) the esterification of desmosterol in J774 macrophages (unpublished data), but this finding does not necessarily indicate the existence of one sterol-esterifying enzyme. Regarding ACAT's sterol specificity, we have shown that exogenous desmosterol is a more potent stimulator of ACAT than exogenous cholesterol in both human and mouse macrophages, despite only slightly greater cellular uptake of desmosterol. Assuming that there is one sterol-esterifying enzyme the explanation for this finding may be that either desmosterol is a better ACAT substrate and/or stimulator than cholesterol, or that desmosterol is transported to the enzyme more efficiently than cholesterol.
Our exploration of the effects of desmosterol on intracellular sterol esterification was undertaken after we discovered that J774 macrophages had a complete defect in cholesterol biosynthesis and instead accumulated desmosterol and desmosteryl ester. The J774 macrophage cell line used in our laboratory (see note added in proof in reference 9) is a unique foam cell model since both native and modified forms of LDL induce CE accumulation (6, 20) , whereas other models (e.g., mouse peritoneal and human monocyte-derived macrophages) accumulate CE only with modified forms of LDL (4) . The ability of J774 macrophages to accumulate CE, especially in the presence of native LDL, is highly dependent on a hyperactive ACAT pathway in these cells (10) . J774 ACAT activity is relatively high even in the absence of exogenous lipoproteins or sterols (see Fig. 3 A and reference 21), and it is precisely under these conditions that the cells synthesize the ACAT stimulator, desmosterol (above). Thus, we initially considered the following hypothesis: before LDL exposure J774 ACAT is maintained in a primed, or active, state by endogenously synthesized desmosterol, and it is this primed ACAT pathway that then contributes to LDL-induced CE accumulation upon subsequent addition of the lipoprotein. However, the data in Fig.  3 support a role for desmosterol in J774 cells only in maintaining high ACAT activity in LPDS (Fig. 3 A) . The ability of LDL to stimulate ACAT activity and CE accumulation in these cells is not dependent on desmosterol-induced stimulation of sterol esterification before LDL addition (Fig. 3 B) .
In summary, we demonstrated that the J774 macrophage foam cell model has a complete defect in cholesterol biosynthesis and accumulates desmosterol and desmosteryl ester. In addition, we have shown that exogenously added desmosterol is a potent stimulator of sterol esterification and sterol ester accumulation in human monocyte-derived macrophages and mouse peritoneal macrophages and that 24-methylene cholesterol also stimulates human macrophage ACAT. There are several potential implications of our findings. With respect to J774 cells, the fact that their sterol content can be made to consist of almost 100% desmosterol (see Results) may be useful in constructing experimental systems in a macrophage foam cell model in which exogenous cholesterol transport and metabolism in the cells and excretion from the cells can be easily distinguished from pathways involving (or complicated by) endogenous cellular sterol. A similar strategy using mouse L cells, a nonmacrophage cell line that also accumulates desmosterol (34) , was used by Rothblat and Buchko (35) . In addition, if the cells are truly lacking the 24-reductase enzyme, the system may be suitable for studying and isolating (e.g., by transfection) the enzyme and its gene. Alternatively, if the enzyme is present but inhibited, aspects of regulation of the 24-reductase pathway may be amenable to study.
With respect to the ability of exogenous desmosterol and 24-methylene cholesterol to stimulate ACAT in human macrophages, our study together with the animal studies (18, 19) and shellfish diet study ( 17) cited above suggests that shellfish containing desmosterol, such as Alaskan king crab and other shellfish (e.g., oysters, clams, and scallops) may be atherogenic. Finally, the lack of ACAT reactivity of most of the xanthomatosis-associated sterols suggests that the excessive foam cell formation seen in these diseases must involve factors other than excessive stimulation of ACAT by the sterols themselves.
